Lisinopril dihydrate is a potent angiotensin-converting enzyme (ACE) inhibitor widely utilized in the treatment of hypertension and heart failure by blocking the conversion of angiotensin I to angiotensin… Read more














Lisinopril dihydrate is a potent angiotensin-converting enzyme (ACE) inhibitor widely utilized in the treatment of hypertension and heart failure by blocking the conversion of angiotensin I to angiotensin II. This collection includes high-quality reference standards for the active pharmaceutical ingredient, alongside essential pharmacopeial and non-pharmacopeial impurities, such as diketopiperazine degradation products and dimeric species. These materials are critical for laboratories conducting rigorous impurity profiling and method validation during pharmaceutical manufacturing. By providing precise identification and quantification capabilities, these compounds—including stable isotope labelled versions—support accurate analysis in high-performance liquid chromatography and other quality control procedures. Researchers rely on these standards to ensure the consistency and compliance of drug products, facilitating reliable results throughout the entire analytical lifecycle of this therapeutic agent.